Remyelination is extensive in a subset of multiple sclerosis patients

Brain

Volumn 129, Issue 12, 2006, Pages 3165-3172

  Patrikios, Peter ^a   Stadelmann, Christine ^c   Kutzelnigg, Alexandra ^b   Rauschka, Helmut ^b   Schmidbauer, Manfred ^b   Laursen, Henning ^d   Sorensen, Per Soelberg ^e   Brück, Wolfgang ^c   Lucchinetti, Claudia ^f   Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f MAYO CLINIC   (United States)

Author keywords

Multiple sclerosis; Remyelination; Shadow plaques

Indexed keywords

MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PLAQUE FORMING CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMYELINIZATION;

EID: 33845294412     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl217     Document Type: Article

References (27)

1. Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003; 60: 1073-81.
2. Bruck W, Schmied M, Suchanek G, Bruck Y, Breitschopf H, Poser S, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994; 35: 65-73.
3. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20: 6404-12.
4. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis [see comment]. N Engl J Med 2002; 346: 165-73.
5. Charcot J. Histologie de la sclerose en plaques. Gazette Hopitaux 1868; 41: 554-66.
6. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002; 125: 1972-9.
7. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124: 1813-20.
8. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705-14.
9. Frohman E, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006; 354: 942-55.
10. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation [see comment]. Nat Med 2002; 8: 1115-21.
11. Kornek B, Storch M, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 2000; 157: 267-76.
12. Kriss A, Francis DA, Cuendet F, Halliday AM, Taylor DS, Wilson J, et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988; 51: 1253-8.
13. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12.
14. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 1983; 25: 1-135.
15. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999; 122: 2279-95.
16. Lumsden CE. The neuropathology of multiple sclerosis and other demyelinating diseases. In: Vinken P, Bruyn GW, eds. Handbook of clinical neurology, Vol 9. Amsterdam: North Holland Publishing 1970:217-309.
17. Marburg O. Die sogennante akute multiple sklerose. Jahrbucher fur Psychiatrie Neurol 1906; 27: 211-312.
18. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
19. Perier O, Gregoire A. Electron microscopic features of multiple sclerosis lesions. Brain 1965; 88: 937-52.
20. Prineas J. The neuropathology of multiple sclerosis. In: Koetsier JC, ed. Handbook of clinical neurology: demyelinating diseases. Vol. 47. Amsterdam: Elsevier; 1985: p 337-95.
21. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993a; 33: 137-51.
22. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993b; 116: 681-93.
23. Prineas JW, Kwon EE, Cho ES, Sharer LR. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann NY Acad Sci 1984; 436: 11-32.
24. Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-204.
25. Schlesinger H. Zur Frage der akuten multiplen Sklerose und der Encephalomyelitis disseminata im Kindesalter. Arbeit Neuro Inst (Wien) 1909; 17: 410-32.
26. Suzuki K, Andrews J.M, Waltz J.M, Terry R.D. Ultrastructural studies of multiple sclerosis. Lab Invest 1969; 20: 444-54.
27. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000; 123: 105-15.